• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Enact Announces 14% Increase to Quarterly Dividend and New $350 Million Share Repurchase Program

    4/30/25 4:10:00 PM ET
    $ACT
    Specialty Insurers
    Finance
    Get the next $ACT alert in real time by email

    RALEIGH, N.C., April 30, 2025 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (NASDAQ:ACT) announced that its Board of Directors declared a quarterly dividend of $0.21 per common share, an increase of 14% from the prior quarter's dividend. This dividend will be payable on June 11, 2025, to shareholders of record on May 19, 2025.

    Additionally, Enact's Board of Directors authorized a new share repurchase program under which the company may purchase up to $350 million of its common stock. The new share repurchase authorization is in addition to the company's current $250 million share repurchase program, of which $6 million remains as of April 25, 2025.

    "Our increased dividend and new share repurchase program reflect our continued commitment to creating value for our shareholders," said Rohit Gupta, Enact's President and Chief Executive Officer. "With today's announcement, we have raised our quarterly dividend every year since its inception three years ago, underscoring the strength of our financial performance and confidence in our business. Going forward we will continue to take a thoughtful and disciplined approach to our capital allocation priorities."

    Enact's new share repurchase program authorizes the purchase of up to $350 million of the company's common stock utilizing a variety of methods, including open market purchases, and privately negotiated transactions, and may be made under Rule 10b5-1 and Rule 10b-18 trading plans, at such times and in such amounts as management deems appropriate. In support, Enact has entered into an agreement with Genworth Holdings, Inc. to repurchase its Enact shares as part of the program to maintain Genworth's current ownership interest in Enact.

    Enact expects the timing and amount of any share repurchases will be opportunistic and will depend on a variety of factors, including Enact's share price, capital availability, business and market conditions, regulatory requirements, and debt covenant restrictions. The program does not obligate Enact to acquire any amount of common stock, it may be suspended or terminated at any time at the Company's discretion without prior notice, and it does not have a specified expiration date.

    About Enact Holdings, Inc.

    Enact (NASDAQ:ACT), operating principally through its wholly-owned subsidiary Enact Mortgage Insurance Corporation since 1981, is a leading U.S. private mortgage insurance provider committed to helping more people achieve the dream of homeownership. Building on a deep understanding of lenders' businesses and a legacy of financial strength, we partner with lenders to bring best-in class service, leading underwriting expertise, and extensive risk and capital management to the mortgage process, helping to put more people in homes and keep them there. By empowering customers and their borrowers, Enact seeks to positively impact the lives of those in the communities in which it serves in a sustainable way. Enact is headquartered in Raleigh, North Carolina.

    This press release was published by a CLEAR® Verified individual.



    Investor Contact
    Daniel Kohl
    [email protected]
    
    Media Contact
    Sarah Wentz
    [email protected]

    Primary Logo

    Get the next $ACT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ACT

    DatePrice TargetRatingAnalyst
    5/5/2025$39.00Outperform → Mkt Perform
    Keefe Bruyette
    12/6/2023$29.00Neutral
    UBS
    11/13/2023$30.00Neutral → Buy
    BofA Securities
    5/9/2023$25.00 → $27.00Underperform → Neutral
    BofA Securities
    2/8/2023$25.00 → $26.50Mkt Perform → Outperform
    Keefe Bruyette
    1/9/2023$24.50Neutral → Underperform
    Credit Suisse
    9/6/2022$27.00Overweight → Neutral
    JP Morgan
    8/18/2022$25.00Neutral → Underperform
    BofA Securities
    More analyst ratings

    $ACT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Enact Holdings downgraded by Keefe Bruyette with a new price target

      Keefe Bruyette downgraded Enact Holdings from Outperform to Mkt Perform and set a new price target of $39.00

      5/5/25 8:29:05 AM ET
      $ACT
      Specialty Insurers
      Finance
    • UBS initiated coverage on Enact Holdings with a new price target

      UBS initiated coverage of Enact Holdings with a rating of Neutral and set a new price target of $29.00

      12/6/23 7:20:51 AM ET
      $ACT
      Specialty Insurers
      Finance
    • Enact Holdings upgraded by BofA Securities with a new price target

      BofA Securities upgraded Enact Holdings from Neutral to Buy and set a new price target of $30.00

      11/13/23 7:12:03 AM ET
      $ACT
      Specialty Insurers
      Finance

    $ACT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Director Restrepo Robert P Jr

      4 - Enact Holdings, Inc. (0001823529) (Issuer)

      6/13/25 4:07:49 PM ET
      $ACT
      Specialty Insurers
      Finance
    • SEC Form 4 filed by EVP, Gen. Counsel & Secretary Stolove Evan

      4 - Enact Holdings, Inc. (0001823529) (Issuer)

      6/13/25 4:07:37 PM ET
      $ACT
      Specialty Insurers
      Finance
    • SEC Form 4 filed by EVP & Chief Operations Officer Gould Brian

      4 - Enact Holdings, Inc. (0001823529) (Issuer)

      6/13/25 4:07:25 PM ET
      $ACT
      Specialty Insurers
      Finance

    $ACT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Genworth Financial Announces Results of Annual Meeting

      Genworth Financial, Inc. (NYSE:GNW) announced the election of all ten director nominees at its 2025 annual meeting of stockholders today. The board members re-elected were G. Kent Conrad, Karen E. Dyson, Jill R. Goodman, Melina E. Higgins, Thomas J. McInerney, Howard D. Mills, III, Robert P. Restrepo Jr., Elaine A. Sarsynski, Ramsey D. Smith, and Steven C. Van Wyk. At the annual meeting, stockholders also approved the advisory vote on named executive officer compensation and the 2025 Omnibus Incentive Plan. In addition, stockholders ratified the selection of KPMG LLP as Genworth's independent registered public accounting firm for 2025. In addition, stockholders approved an amendment to th

      5/22/25 1:32:00 PM ET
      $ACT
      $GNW
      Specialty Insurers
      Finance
      Life Insurance
    • Enact Reports First Quarter 2025 Results

      GAAP Net Income of $166 million, or $1.08 per diluted share Adjusted Operating Income of $169 million, or $1.10 per diluted share Return on Equity of 13.1% and Adjusted Operating Return on Equity of 13.4% Primary Insurance in-force of $268 billion, a 2% increase from first quarter 2024 PMIERs Sufficiency of 165% or approximately $2.0 billion Book Value Per Share of $33.96 and Book Value Per Share excluding AOCI of $34.97 RALEIGH, N.C., April 30, 2025 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (NASDAQ:ACT) today announced financial results for the first quarter of 2025. "We had a strong start to 2025 and continue to make progress against our priorities," stated Rohit Gupta, President a

      4/30/25 4:20:32 PM ET
      $ACT
      Specialty Insurers
      Finance
    • Genworth Financial Announces First Quarter 2025 Results

      Strategic Highlights Executed $45M in share repurchases at an average price of $6.91 per share; $590M program-to-date through March 31, 2025 at an average price of $5.73 per share Continued progress on the LTC1 multi-year rate action plan with $24M of gross incremental premium approvals; approximately $31.3B estimated net present value achieved since 2012 from in-force rate actions (IFAs) Strong progress made towards the expansion of the CareScout Quality Network, growing coverage to 90% of the aged 65-plus census population in the United States and delivered 576 matches in the first quarter Financial Highlights Net income2 of $54M, or $0.13 per diluted share, and adjusted operati

      4/30/25 4:15:00 PM ET
      $ACT
      $GNW
      Specialty Insurers
      Finance
      Life Insurance